The News Review:

- Cape Cod Clinical Research Inc. Launches TrialDCS¢
- Altarum buys KAI Research
- KU and K-State Join Forces in Cancer Research
- Alnylam Pharmaceuticals Inc elects Akshay Vaishnaw as senior vice …
- Corporate lawyer sells to Abbott research manager
- Clinical Research

Cape Cod Clinical Research Inc. Launches TrialDCS¢
SYS-CN Media NJ 
Cape Cod Clinical Research Inc. Launches TrialDCS? | SYS-CN UK.

Altarum buys KAI Research
Bizjournals.com NC 
Rockville-based KAI will become a for-profit wholly-owned subsidiary and will continue to operate from its current headquarters. It is currently providing safety surveillance for dozens of ongoing clinical trials. “KAI’s support of clinical research and science-based innovation in health care provides critical new technical capabilities and market presence for Altarum” said Lincoln Smith president and chief executive of Ann Arbor Mich. -based Altarum a nonprofit that employs more than 350 people. Altarum relies on research and client-centered consulting skills to help improve health and health care. KAI founded in 1986 employs about 70 employees and generated more than $10 million in revenue last year. Its clinical research and information technology capabilities support potential preventive diagnostic and therapeutic measures in health care practice.

KU and K-State Join Forces in Cancer Research
KCUR M 
The agreement allows eligible scientists at K-State to become adjunct professors at KU. It also gives scientists at both places greater access to each other’s cancer facilities and confidential research. Rob Denell is director of K-State’s Cancer Institute and says the new agreement will bring about more collaborations between the scientists focusing on basic research at K-State and the scientists focusing on clinical research at KU. Denell: “Basically from our point of view what we anticipate is that it’s going to allow our scientists more access to clinical material that it’s going to facilitate having our basic research potentially move in to clinical trials and other kinds of actual applications. ” KU says the agreement marks a big step in its efforts to become a nationally designated Cancer Institute. Funding for health care coverage on KCUR has been provided by the Health Care Foundation of Greater Kansas City. Download recent health stories or subscribe to the.

Alnylam Pharmaceuticals Inc elects Akshay Vaishnaw as senior vice …
Trading Markets (press release) CA 
He led the pre-clinical and clinicaladvancement of the Alnylam’s pipeline of RNAi therapeutics includingALN-RSV01 for the treatment of RSV infection and ALN-VSP for thetreatment of liver cancers as well as other programmes in the areas ofhypercholesterolemia Huntington’s disease and transthyretin (TTR)amyloidosis. He has also served as a member of Alnylam’s managementteam. Previously Vaishnaw served as senior director of TranslationalMedicine at Biogen Idec and spent seven years with the company. Additionally the company stated that Vaishnaw has published papers inleading scientific journals and has also authored a number of textbookchapters relating to autoimmune disease.

Corporate lawyer sells to Abbott research manager
Blockshopper IL 
Sicam serves as a senior clinical research manager in oncology at Abbott Laboratories a global broad-based health care company. She was an associate director in clinical operations at Introgen Therapeutics Inc. and a clinical project coordinator at Eisai Medical Research. She has also worked as a clinical research associate at Quintiles Inc.
Related from Medcylopaedia: Abbott To Buy Advanced Medical For $1.36 Billion

Clinical Research
Hays Pharma UK 
00 per annumLocationEngland – Berkshire28 Jan 2009A great opportunity has come about for a Clinical Research Associate 2 position. You would be working for a CR is a growing and developing market and they have great opportunities for you to develop. The main purpose of the Clinical Research Associate position is to prepare and performs closeout visits according to the protocol local laws ICH-GCP and Companies SPs. Also to perform initiation visits trains investigators and other trial staff in the protocol and data collection methods to ensure collection of patient data is accurate complete and conforms to protocol requirements in accordance with local regulations ICHGCP and the companies SPsFor further information please contactDavid NixonEmail:.